Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy

Archives of Dermatology

Volumn 144, Issue 7, 2008, Pages 851-858

  Wang, Frank ^a   Garza, Luis A ^a,c   Cho, Soyun ^a,d   Kafi, Reza ^a,e   Hammerberg, Craig ^a   Quan, Taihao ^a   Hamilton, Ted ^a   Mayes, Maureen ^b,f   Ratanatharathorn, Voravit ^a,g   Voorhees, John J ^a   Fisher, Gary J ^a   Kang, Sewon ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Seoul National University College of Medicine   (South Korea)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROCOLLAGEN; STROMELYSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MALE; PHOTOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RATING SCALE; SCLERODERMA; SCORING SYSTEM; SKIN PIGMENTATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET IRRADIATION;

ADULT; COLLAGEN TYPE I; COLLAGEN TYPE III; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; HYPERPIGMENTATION; MALE; MATRIX METALLOPROTEINASES; POLYMERASE CHAIN REACTION; RADIATION DOSAGE; RNA, MESSENGER; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 47849086393     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.7.851     Document Type: Article

References (28)

1. Charles C, Clements P, Furst DE. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet. 2006;367(9523):1683-1691.
2. Denton CP, Black CM. Targeted therapy comes of age in scleroderma. Trends Immunol. 2005;26(11):596-602.
3. Breuckmann F, Gambichler T, Altmeyer P, Kreuter A. UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol. 2004;4(1):11.
4. Fisher GJ, Kang S. Phototherapy for scleroderma: biologic rationale, results, and promise. Curr Opin Rheumatol. 2002;14(6):723-726.
5. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2(3):134-144.
6. Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38(2):113-116.
7. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 1979; 22(2):130-140.
8. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol. 1994; 103(3):359-363.
9. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res. 1991; 283(8):506-511.
10. Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335-339.
11. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337 (20):1419-1428.
12. Mempel M, Schmidt T, Boeck K, et al. Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy. Br J Dermatol. 2000;142(3):473-480.
13. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54(3):440-447.
14. Calzavara Pinton P, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica. 2003;88(10):1169-1175.
15. Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol. 2004;50(5): 740-747.
16. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol. 2001;18(3):241-245.
17. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed. 2001;17(4):149-155.
18. von Kobyletzki G, Uhle A, Pieck C, Hoffmann K, Altmeyer P. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol. 2000;136(2):275-276.
19. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy [letter]. Lancet. 1995;346(8983):1166.
20. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet. 1997;350(9087):1295-1296.
21. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 1997;36(6, pt 1):938-944.
22. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38(1):21-26.
23. Westerhof W, Estevez-Uscanga O, Meens J, Kammeyer A, Durocq M, Cario I. The relation between constitutional skin color and photosensitivity estimated from UV-induced erythema and pigmentation dose-response curves. J Invest Dermatol. 1990;94(6):812-816.
24. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166(6):1691-1699.
25. Ravnbak MH, Wulf HC. Pigmentation after single and multiple UV-exposures depending on UV-spectrum. Arch Dermatol Res. 2007;299(1):25-32.
26. Denton CP, Black CM. Scleroderma (systemic sclerosis). In: Wolff K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw-Hill Medical Publishing Division; 2008:1553-1562.
27. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A. 1993;90(14):6666-6670.
28. Staberg B, Wulf HC, Klemp P, Poulsen T, Brodthagen H. The carcinogenic effect of UVA irradiation. J Invest Dermatol. 1983;81(6):517-519.